Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Learn about the connection between hidden heart fat and inflammation and blood vessel problems. Find out why this fat can ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

GLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...

Peptidomics offered new diagnostic insights into the underlying processes of metabolic dyfunction-associated steatotic liver ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

While we’re unlikely to see a dramatic rise in deaths from vaccine-preventable diseases in the U.S. in the near term, the ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.